1Link H, Xiao BG. Rat models as tool to develop new immunotherapies[J]. Immunol Rev,2001,184:117-128.
2Levinson AI, Wheadey LM. The Thymus and the Pathogenesis of Myasthenia gravis[J].Clin Immunol Immunopathol,1996,78(1):1-5.
3Remes-Troch JM, Tellez-Zenteno JF, Estanol B, et al. Thymectomy in myasthenia gravis: response, complications,and associated conditions [J]. Arch Med Res, 2002,33(6):545-551.
4Pagel CN, Morgan JE, Gross JG, et al. Thymic myoid cells as a source of cells for myoblast transfer[J]. Cell Transplant,2000,9(4):531-538.
5Wong A,Garrett KL,Anderson JE. Myoid cell density in the thymus is reduced during mdx dystrophy and after muscle rush[J].Biochem Cell Biol,1999,77:33-40.
6Patrick J, Lindstrom JM, Culp B, et al. Studies on Purefred eel acetylcholine receptor and anti-acetylchol-ine receptor antibody[J]. Proc Nat Acad Sci, 1973,70:3334-3338.
7Navaneetham D, Penn AS, Howard JF, et al. Human thymuses express incomplete sets of muscle acetylcho-line receptor subunit transcripts that seldom include the delta subunit. [J]. Muscle Nerve, 2001,24(2):203-210,
8Zhang GX, Xiao BG, 13akhiet M, et al. Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis[J]. Exp Med, 1996, 184:349-359.
9Nagane y, Utsugisawa K, Obara D, et al . NKT-asociated marks and perforin in hyperplastic thymuses from patient with MG[J]. Muscle Nerve, 2001,24(10):1359-1364.
10Defilippi VJ,Richman DP,Ferguson MK. Transcervical thymectomy for myasthenia gravis[J]. Ann Thorac Surg,1994,57(3): 194-197.
